A powerful new alopecia pill, called Ruxolitinib, is good news for individuals who suffer from baldness because the so-called wonder pill fully restored the hair of three patients within just a few months of being put on the drug. But as explained in an Aug. 17 Live Science report, the bad news is that appears to be effective only for treating alopecia areata and - at least for the moment - not androgenetic alopecia.
Regarding the alopecial pill breakthrough, lead researcher Dr Raphael Clynes said..."We've only begun testing the drug in patients, but if the drug continues to be successful and safe, it will have a dramatic positive impact on the lives of people with this disease."
This promising pill that can cure baldness was initially tested in laboratory animals, with surprising results. And now, human experimentation has been a success. The patients in the test phase, three men who were completely bald, took two pills a day for five months. At the end of the treatment all men experienced total hair regrowth.
Scientists were able to identify the immune cells responsible for the atrophy of the hair follicle in alopecia areata, and Ruxolitinib is able to stop the action of these cells. Doctors conducted the pilot trial after this find.
"Additional clinical trials are needed to test the effectiveness of this drug in more patients in larger studies," said study author Angela M. Christiano, a professor of dermatology and genetics at Columbia University Medical Center in New York.
As mentioned above, unfortunately Ruxolitinib is not effective for people suffering from androgenetic alopecia, a common form of hair loss in both men and women. In men, this condition is also known as male-pattern baldness.